Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Nature Communications|June 22, 2016
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progressionWen Cai Zhang, Tan Min Chin, Henry Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Targeted Oncology|January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in ChinaHai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
Nature Medicine|May 8, 2019
Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Plos One|May 9, 2015
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAmit Jain, Cindy Lim, Eugene MingJin Gan, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Immunity|August 14, 2016
A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine SignaturesMichael Thomas Wong, David Eng Hui Ong, Frances Sheau Huei Lim, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Nature Communications|June 22, 2016
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progressionWen Cai Zhang, Tan Min Chin, Henry Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Targeted Oncology|January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in ChinaHai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
Nature Medicine|May 8, 2019
Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Plos One|May 9, 2015
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAmit Jain, Cindy Lim, Eugene MingJin Gan, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Immunity|August 14, 2016
A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine SignaturesMichael Thomas Wong, David Eng Hui Ong, Frances Sheau Huei Lim, et al.
Pageof 11